What is Malnutrition?
|
|
- Jasmine Marshall
- 5 years ago
- Views:
Transcription
1 HIV & Obesity Gail Shor-Posner, PhD Director, Division of Disease Prevention Department of Epidemiology & Public Health University of Miami Miller School of Medicine
2 What is Malnutrition? Under-nutrition Over-nutrition
3 Malnutrition Wasting
4 HIV & Disease Progression
5 Benefits of Obesity in HIV Patients Shor-Posner, et al. (2000) When Obesity is Desirable: A Longitudinal Study of the Miami HIV-1-Infected Drug Abusers (MIDAS) Cohort. JAIDS
6 HIV Obesity & Disease Progression Shor-Posner, et al. (2000) When Obesity is Desirable: A Longitudinal Study of the Miami HIV-1-Infected Drug Abusers (MIDAS) Cohort. JAIDS
7 Obesity among patients with HIV: The latest epidemic Studies show that 6 out of 10 HIV+ people are overweight/obese More than 70% of the patients were on HAART at the time of the study. Neither duration of HAART nor the type of regimen influenced BMI values. (Amorosa, 2005) Crum et al. (2008) Obesity among patients with HIV: The latest epidemic. AIDS patient care and STDs. Amorosa V et al. (2005) A tale of two epidemics. The intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr
8 HIV Obesity trends are mirroring Global Obesity
9 Malnutrition Obesity MODERN HUMANS
10
11 Obesity in Latin America Rueda-Clausen a, Silva a and López-Jaramillo (March 2008) Epidemic of overweight and obesity in Latin America and the Caribbean, International Journal of Cardiology.
12 Obesity in Colombia Obesity in Colombia approx 40%???
13 Causes of Global Obesity Environmental Influences Portion distortion Less physical activity Greater reliance on technology Pawloski, L. 26 February Department of Global Health & Community Health
14 From Ancient to Modern Diet Lin Khor, G. (2006). 33 rd Session of the SCN, Universiti Putra Malaysia, Geneva.
15 From Ancient to Modern Transportation Lin Khor, G. (2006). 33 rd Session of the SCN, Universiti Putra Malaysia, Geneva.
16 Why Worry? Obesity is linked with Increased risk of cardiovascular disease Increased risk of Diabetes Cancer Depression
17 What has happened in HIV? ARV Therapy Living Longer Survival Rates
18 HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) Benefits Longer survival Improved quality of life Adverse effects Lipodystrophy syndrome DM2 Alterations in glucose and lipid metabolism Insulin resistance Increase in cardiovascular risk IDF Cape Town Report (April 2007)10 th Meeting of the Mediterranean Group for the Study of Diabetes
19 Lipodystrophy Apparent in 20-35% of patients after months of drug therapy, HIV itself Subcutaneous lipoatrophy Face, limbs, buttocks Fat accumulation Visceral Dorsocervicalspine ( buffalo hump ) Lipomata Breast enlargement Heath KV, JAIDS 2002;30:440-7 & Bastard JP, Lancet 2002;359: GrinspoonS, NEJM 2005;352:48-62
20 Facial Lipoatrophy Korthuis, T. (2006). Metabolic Complications of Antiretroviral Therapy. OHSU HIV Program.
21 Dorsocervical Spine Fat Accumulation Korthuis, T. (2006). Metabolic Complications of Antiretroviral Therapy. OHSU HIV Program.
22 Central Fat Accumulation Korthuis, T. (2006). Metabolic Complications of Antiretroviral Therapy. OHSU HIV Program.
23 Limb Lipoatrophy
24 HIV-Related Metabolic Complications Lipid(cholesterol /triglyceride) abnormalities Abnormal blood sugar (glucose) metabolism Mitochondrial toxicity Body fat redistribution Bone One syndrome or several? One etiology or multifactorial?
25 HIV & CARDIAC RISK Vergel, N. Beyond HIV Survival: Enhancing Health & Body Shape in the post-haart era. Powerusa.org.
26 Vergel, N. Beyond HIV Survival: Enhancing Health & Body Shape in the post-haart era. Powerusa.org.
27 DIABETES AND AIDS TWO EPIDEMICS OF XXI CENTURY 0.3% 0.9% 0.1% Diabetes prevalence 0.8% 1.2% 0.2% 0.6% 0.5% 5.9% 0.4% AIDS prevalence
28 Insulin Resistance and HIV Venter - The New HIV Precipe? Metabolic Disorders. Reproductive Health & HIV Research Unit. University of Watersrand
29 MULTICENTER AIDS COHORT STUDY Incidence of DM in HIV+ patients with HAART exposure 4 X greater than HIV-controls 568 HIV + men - HAART 710 HIV - men Adjusted for age, BMI DM in HIV + rate: 4.7 cases per 100 person/yr DM in HIV- rate: 1.4 cases per 100 person/yr Arch Inter Med 2005, 165: 1179 IDF Cape Town Report (April 2007)10 th Meeting of the Mediterranean Group for the Study of Diabetes
30 DISORDERS OF GLUCOSE METABOLISM IN HIV INFECTED PATIENTS ON TREATMENT 61% of patients develop insulin resistance 14% of patients develop Metabolic Syndrome A collection of metabolic risk factors that accelerate the onset of: diabetes, heart disease, stroke, and certain cancers IDF Cape Town Report (April 2007)10 th Meeting of the Mediterranean Group for the Study of Diabetes
31 Metabolic Syndrome Abdominal obesity Elevated TRIG Low HDL Hypertension Hyperglycemia Ackerman, P. Metabolic Syndrome and its Relation to Chronic Disease. UP Diabetes Outreach Network.
32 HIV Patients and risk for metabolic syndrome Metabolic Syndrome is more prevalent in HIVseropositive than HIV-seronegative women due to dyslipidemias. -- Sobieszczyk, et al. (2008). Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women s Interagency HIV Study. JAIDS, 48:, Metabolic Syndrome prevalence in HIVpositive adults was lower than in the general population. Samaras et al. (2007). Prevalence of metabolic syndrome in HIVinfected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and adult treatment panel III criteria. DiabeCare, 30, The prevalence of Metabolic Syndrome among HIV-infected patients is similar to that in uninfected individuals. Jericó, et al. (2005). Metabolic syndrome among HIV-infected patients: Prevalence, characteristics, and related factors. Diab Care, 28,
33 Potential Mechanisms for Metabolic Abnormalities Vessels Increased trygliceride in circulation Increased apolipoprotein E Decreased degradation of Lipoprotein B Liver Decreased mitochondrial fatty acid oxidation Increased lipid accumulation and hepatic steatosis Fat Increased lipolysis Decreased subcutaneous fat Decreased SRBP1-activated PPAR expression Toxic effect on mitochondria Pancreas Increased insulin secondary to resistance Muscle Decreased glucose Transport (GLUT 4) Increased intramyocellular lipid and fatty acid oxidation IDF Cape Town Report (April 2007)10 th Meeting of the Mediterranean Group for the Study of Diabetes
34 What Do We Know? Traditional lifestyle risks are most important in HIV for cardiovascular risks Same in diabetes Venter - The New HIV Precipe? Metabolic Disorders. Reproductive Health & HIV Research Unit. University of Watersrand
35 CONCLUSIONS Obesity is an emerging health problem among HIV+ men and women Metabolic and body-fat abnormalities are common among ARV treated HIV+ adults Preliminary evidence suggests that such patients have an increased risk of cardiovascular disease. Clinicians caring for HIV-infected adults should assess cardiovascular risk factors and target risk reduction, though not at the expense of successful treatment of the underlying HIV disease. Diet, lifestyle modification, and use of lipid-lowering and insulinsensitizing regimens may be useful in specific situations. Role of intentional weight loss in obese HIV will need careful study, as weight loss is a documented predictor of decreased survival.
36 Acknowledgements Victoria Elf
Didactic Series. Lipohypertrophy in HIV
Didactic Series Lipohypertrophy in HIV Daniel Lee, MD Clinical Professor of Medicine UCSD Medical Center Owen Clinic August 14th, 2014 ACCREDITATION STATEMENT: University of California, San Diego School
More informationFat redistribution on ARVs: dogma versus data
Fat redistribution on ARVs: dogma versus data Gary Maartens Division of Clinical Pharmacology UNIVERSITY OF CAPE TOWN IYUNIVESITHI YASEKAPA UNIVERSITEIT VAN KAAPSTAD Half of what we are going to teach
More informationΛΟΙΜΩΞΗ HIV. Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική
ΛΟΙΜΩΞΗ HIV Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική Κλινική, Νοσοκομείο «Αττικόν» Infection Acute Myocardial Infarction p er 100,000 HIV/AIDS discharg es 800 700 600 500 400 300 200
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationTest5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight
Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the registered trademarks of Quest
More informationLaboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011
Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationLa sindrome metabolica e il suo impatto dopo la guarigione nel paziente HIV/HCV
WORKSHOP HCV: la guarigione e il parallelismo tra risposta virologica sostenuta e outcome clinico Milano, 25 Ottobre 2018 Ospedale San Raffaele IRCCS - Sede Turro La sindrome metabolica e il suo impatto
More informationOptimizing Health While Aging with HIV
Slide 1 Optimizing Health While Aging with HIV Todd T. Brown, MD, PhD Division of Endocrinology and Metabolism Johns Hopkins University Unfortunately, We are Not Slide 2 Immortal But How Do We Want to
More informationObesity, Metabolic Syndrome, and Diabetes: Making the Connections
Obesity, Metabolic Syndrome, and Diabetes: Making the Connections Alka M. Kanaya, M.D. Associate Professor of Medicine & Epi/Biostats University of California, San Francisco February 26, 21 Roadmap 1.
More informationHIV Infection as a Chronic Disease. Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School
HIV Infection as a Chronic Disease Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School Role of Primary Care Approximately 50,000 patients are diagnosed with HIV infection annually
More informationHormonal and Metabolic Disorders of Human Immunodeficiency Virus Infection and Substance Abuse
American Journal of Infectious Diseases 2 (3): 125-129, 2006 ISSN 1553-6203 2006 Science Publications Hormonal and Metabolic Disorders of Human Immunodeficiency Virus Infection and Substance Abuse Jag
More informationB. Patient has not reached the percentage reduction goal with statin therapy
Managing Cardiovascular Risk: The Importance of Lowering LDL Cholesterol and Reaching Treatment Goals for LDL Cholesterol The Role of the Pharmacist Learning Objectives 1. Review the role of lipid levels
More informationWhat is Diabetes Mellitus?
Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates
More informationMechanisms and Strategies for Insulin Resistance in Acquired Immune Deficiency Syndrome
SUPPLEMENT ARTICLE Mechanisms and Strategies for Insulin Resistance in Acquired Immune Deficiency Syndrome Steven Grinspoon Harvard Medical School, Massachusetts General Hospital, Program in Nutritional
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationMetabolic Syndrome.
www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More informationRehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD
Disclosure The contents of this presentation were developed with support from educational grants from the Department of Education, NIDRR grant numbers H133B090005, H133B970011 and H133G010160. However,
More informationIJBCP International Journal of Basic & Clinical Pharmacology
Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20172719 Original Research Article Prevalence of
More informationDIABETES. A growing problem
DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought
More informationTOXICITY, TOLERABILITY, AND ADHERENCE TO THERAPY
SAFETY AND TOLERABILITY OF CURRENTLY AVAILABLE ANTIRETROVIRAL AGENTS * Esteban Martinez, MD, PhD ABSTRACT Safety and tolerability are important factors to consider when instituting or modifying therapy
More informationEffects of Exercise and Physical Activity on Diabetes Mellitus and Obesity
1 EXERCISE IS MEDICINE: The Science Behind the Movement Effects of Exercise and Physical Activity on Diabetes Mellitus and Obesity Rosa Allyn G. Sy, MD, FPCP, FPSEDM Endocrinology, Diabetes, Metabolism
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationComprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium
Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:
More informationMedical Nutrition Therapy
CATEGORY: CHRONIC DISEASE PREVENTION AND MANAGEMENT An unhealthy dietary pattern is a common, modifiable risk factor associated with chronic disease and metabolic syndrome. Sessions within this category
More informationRoadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total
Diabetes and the Metabolic Syndrome in the Asian Population Alka Kanaya, MD Associate Professor of Medicine, UCSF Feb 26, 2010 Roadmap 1. Diabetes in Asian Americans Prevalence in the U.S. Risk factors
More informationEffective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.
Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could
More informationResearch Article Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors
Hindawi BioMed Research International Volume 2017, Article ID 7481597, 14 pages https://doi.org/10.1155/2017/7481597 Research Article Metabolic Disorders in HIV-Infected Adolescents Receiving Protease
More informationA Pilot Study of Exercise Training to Reduce Trunk Fat in Adults With HIV Associated Fat Redistribution
A Pilot Study of Exercise Training to Reduce Trunk Fat in Adults With HIV Associated Fat Redistribution Ronenn Roubenoff, Lauren Weiss, Ann McDermott, Tanya Heflin, Gregory J. Cloutier, Michael Wood and
More informationCHAPTER IV RESEARCH METHOD. This study belongs to the field of Internal Medicine, specifically the field
CHAPTER IV RESEARCH METHOD 4.1 Research fields This study belongs to the field of Internal Medicine, specifically the field of Infectious and Tropical Disease. 4.2 Research location and period This study
More informationWhen to Rock the Boat Switching Antiretroviral Therapy for Metabolic Complications
When to Rock the Boat Switching Antiretroviral Therapy for Metabolic Complications 12 th Annual Tennessee AETC/CCC HIV Symposium 6 November 2009 Todd Hulgan, MD, MPH Assistant Professor of Medicine Division
More informationDirector, Employee Health & Productivity. Coordinator, Employee Health & Productivity
Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol
More informationFructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희
Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희 Introduction Unique characteristics of Fructose Metabolism Mechanism for Fructose-Induced Insulin Resistance Epidemiological Studies
More information3TC (lamivudine, Epivir)
FACTSHEET 3TC (lamivudine, Epivir) Summary 3TC is a type of antiretroviral drug called a nucleoside analogue (or nuke ). 3TC can cause nausea, headache, diarrhea, vomiting and weakness; however, it causes
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationPIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia
PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,
More informationTesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies
Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationUMHS-PUHSC JOINT INSTITUTE
Role of Visceral Adiposity in the Pathogenesis of Non-Alcoholic Fatty Liver Disease in Lean versus Obese Patients: A Comparative Study between Patients at UMHS versus PUHSC Lai WEI and Anna LOK W Zhang,
More informationSession 21: Heart Health
Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationCardiovascular Disease Risk Factors:
Cardiovascular Disease Risk Factors: Risk factors are traits or habits that increase a person's chances of having cardiovascular disease. Some risk factors can be changed. These risk factors are high blood
More informationA Central Role of MG53 in Metabolic Syndrome. and Type-2 Diabetes
A Central Role of MG53 in Metabolic Syndrome and Type-2 Diabetes Yan Zhang, Chunmei Cao, Rui-Ping Xiao Institute of Molecular Medicine (IMM) Peking University, Beijing, China Accelerated Aging in China
More informationHIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS
HIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS Evolving Health Care Needs of People Aging with HIV in Washington, DC Matthew E. Levy 1, Alan E. Greenberg 1, Rachel Hart
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationNutrition and HIV/AIDS
Nutrition & HIV Gail Shor-Posner, PhD Director & Professor Division of Disease Prevention Department of Epidemiology & Public Health University of Miami Miller School of Medicine Nutrition and HIV/AIDS
More informationADVANCED CARDIOMETABOLIC SCREENING
ADVANCED CARDIOMETABOLIC SCREENING INTRODUCTION SignatureMD and its affiliated physicians continuously seek out technology to identify health risk factors before they become serious diseases. SignatureMD
More informationNutritional status strongly influences the well-being and survival of individuals
1 6 A D D I C T I O N S C I E N C E & C L I N I C A L P R A C T I C E A P R I L 2 0 0 9 Nutrition Issues in Chronic Drug Users Living With HIV Infection Human immunodeficiency virus (HIV) infection and
More informationMetabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah
Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for
More informationOutline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose
Nutritional, Metabolic, and Gastrointestinal Complications in Pediatric HIV Infection Tracie L. Miller, MD Department of Pediatrics University of Miami, Miller School of Medicine I have no financial relationships
More informationObesity in the pathogenesis of chronic disease
Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,
More informationComplications of HIV Infection and Antiretroviral Therapy
International AIDS Society USA Topics in HIV Medicine Complications of HIV Infection and Antiretroviral Therapy Diane V. Havlir, MD, and Judith S. Currier, MD Metabolic Complications Atherosclerosis and
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationThe multiple burden of malnutrition and healthy diets
The multiple burden of malnutrition and healthy diets F.Branca Director Department of Nutrition for Health and development WHO/HQ Acting Executive Secretary SCN 1 Leading risk factors for global burden
More informationDietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and
Dietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and Dietetics Tehran University of Medical Sciences Honorary Academic
More informationLipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
More informationCorrelation between ABO blood group and Dyslipidemia with Metformin therapy in newly diagnostic type 2 Diabetes Mellitus
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.10 No.4, pp 77-83, 2017 Correlation between ABO blood group and Dyslipidemia with Metformin therapy
More information3TC (lamivudine, Epivir)
3TC (lamivudine, Epivir) Summary 3TC is a type of antiretroviral drug called a nucleoside analogue (or nuke ). 3TC can cause nausea, headache, diarrhea, vomiting and weakness; however, it causes few side
More informationNURSING CARE. HIV-Infected INMATE. of the. METABOLIC COMPLICATIONS of HIV. Albany Medical Center. Module 9 S U M M E R / F A L L
NURSING CARE of the HIV-Infected INMATE METABOLIC COMPLICATIONS of HIV Module 9 S U M M E R / F A L L 0 0 7 Albany Medical Center This learning activity is co-provided by The Albany Medical Center Hospital
More informationColleen Hadigan, 1 Shafali Jeste, 1 Ellen J. Anderson, 2 Rita Tsay, 3 Helen Cyr, 3 and Steven Grinspoon 1. Kenneth H. Mayer, Section Editor
HIV/AIDS Kenneth H. Mayer, Section Editor MAJOR ARTICLE Modifiable Dietary Habits and Their Relation to Metabolic Abnormalities in Men and Women with Human Immunodeficiency Virus Infection and Fat Redistribution
More informationKey Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management. Carmen Ritz, MS Clinical Physiologist
Key Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management Carmen Ritz, MS Clinical Physiologist The Ideal Biomarker to identify risk for CVD Specific accurately identifies
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationRick Fox M.A Health and Wellness Specialist
Metabolic Diseases Rick Fox M.A Health and Wellness Specialist Metabolic Diseases Metabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates
More informationTHE BURDEN OF METABOLIC DISEASES AMONGST HIV POSITIVE PATIENTS ON HAART ATTENDING
THE BURDEN OF METABOLIC DISEASES AMONGST HIV POSITIVE PATIENTS ON HAART ATTENDING THE JOHANNESBURG HOSPITAL Henry P Julius Research report submitted to the Faculty of Health Science, University of the
More informationJAIDS Journal of Acquired Immune Deficiency Syndromes 31: Lippincott Williams & Wilkins, Inc., Philadelphia. Rapid Communications
JAIDS Journal of Acquired Immune Deficiency Syndromes 31:257 275 2002 Lippincott Williams & Wilkins, Inc., Philadelphia Rapid Communications Management of Metabolic Complications Associated With Antiretroviral
More informationA study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital
Original Research Article A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital M. Arivumani * Assistant Professor of General Medicine, Government
More informationClinical Epidemiology of Frailty in HIV Infection. Joseph B. Margolick, MD, PhD Johns Hopkins Bloomberg School of Public Health
Clinical Epidemiology of Frailty in HIV Infection Joseph B. Margolick, MD, PhD Johns Hopkins Bloomberg School of Public Health HIV and Aging 4 Similarities between HIV and aging at the biological level
More informationNon alcoholic fatty liver disease and atherosclerosis Raul Santos, MD
Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Sao Paulo Medical School Hospital Sao Paulo, Brazil Disclosure Honoraria received for consult and/or speaker : Astra Zeneca, Amgen,
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationOptimizing Postpartum Maternal Health to Prevent Chronic Diseases
Optimizing Postpartum Maternal Health to Prevent Chronic Diseases Amy Loden, MD, FACP, NCMP Disclosures Research: None Financial: none applicable to this presentation PRIUM QEssentials Market Research
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationHSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME
HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME What does the term Metabolic Syndrome describe? Metabolic syndrome describes a cluster of cardio-metabolic conditions that increase one's risk of developing
More informationMOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel
More informationObjectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT
Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of
More informationASSOCIATION BETWEEN DIETARY CALCIUM INTAKES AND WEIGHT LOSS
ASSOCIATION BETWEEN DIETARY CALCIUM INTAKES AND WEIGHT LOSS Presented By: Prof. Mohamed S. Ismail Institution Current: Dept. Clin. Nutr. Univ. Of Dammam, KSA Permanent: Nutr. Food Sci. Menoufia Univ. Egypt
More informationREFERENCE CODE GDHCER022 PUBLICAT ION DATE AUGUST 2013 OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
REFERENCE CODE GDHCER022 PUBLICAT ION DATE AUGUST 2013 OVERWEIGHT AND OBESITY - Executive Summary Obesity is an escalating global public health problem that has reached pandemic proportions. It is caused
More informationGrowth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials
DOI: 10.1111/j.1468-1293.2010.00906.x r 2011 British HIV Association HIV Medicine (2011), 12, 453 462 REVIEW Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled
More informationCardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
The new england journal of medicine review article From the Program in Nutritional Metabolism and the Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston (S.G.); and
More informationDiscussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting
Session #5 Cardiometabolic Risk Management in the Primary Care Setting Sonja Reichert, MD MSc FCFP FACPM Betty Harvey, RNEC BScN MScN Amanda Mikalachki, RN BScN CDE S Discussion points Whom should we be
More informationMonitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy
HORMONES 2011, 10(2):149-155 Research paper Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy Vana Spoulou, 1 Christina Kanaka-Gantenbein, 1
More informationBiochemistry of Nutrition. Prof K Syed Department of Biochemistry & Microbiology University of Zululand Room no. 247
Biochemistry of Nutrition Prof K Syed Department of Biochemistry & Microbiology University of Zululand Room no. 247 SyedK@unizulu.ac.za Unit 5 Malnutrition (dietary excesses & deficiencies) Obesity Kwashiorkor
More informationHyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi
Hyperlipidemia Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi Outline The story of lipids Definition of hyperlipidemia Classification of hyperlipidemia Causes of hyperlipidemia
More informationAssessment of Liver Stiffness by Transient Elastography in Diabetics with Fatty Liver A Single Center Cross Sectional observational Study
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 6 Ver. IV (June. 2017), PP 49-53 www.iosrjournals.org Assessment of Liver Stiffness by Transient
More informationUpdate On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?
Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACC/AHA. See American College of Cardiology/ ACE inhibitors. See Angiotensin-converting enzyme (ACE) inhibitors American College of Cardiology/American
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationKnow Your Numbers. Your guide to maintaining good health. Helpful information from Providence Medical Center and Saint John Hospital
Know Your Numbers Your guide to maintaining good health Helpful information from Providence Medical Center and Saint John Hospital If it has been awhile since your last check up and you are searching for
More informationChapter (5) Etiology of Low HDL- Cholesterol
Chapter (5) Etiology of Low HDL- Cholesterol The aim of this chapter is to summarize the different etiological factors mainly the role of life-style and different disease conditions contributing to the
More informationCardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az
Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of
More informationCardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009
Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Content Introduction The number 1 killer in America Some statistics
More informationSituación actual de los pacientes VIH+ Esteban Martínez Hospital Clínic Barcelona
Situación actual de los pacientes VIH+ Esteban Martínez Hospital Clínic Barcelona Mortality per 1 patient-years HIV infection has changed from a fatal disease into a chronic condition This means long-term
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationMETABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University
More informationYour health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect
Your health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect your health and well-being. Knowing your medical history
More information2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP
Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology
More information